ArticleFrontiers in artificial intelligence2026
Symptoms and causes of obstacles in AI-based telemonitoring: strategies for system development through a CRISP-DM lens.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic diseases, particularly heart failure (HF), impose a substantial clinical and socioeconomic burden worldwide. AI-based telemonitoring holds significant promise for improving chronic disease management through continuous monitoring and early detection of deterioration. However, translation into routine clinical practice remains limited due to challenges regarding data quality, transparency, regulation, and integration into established clinical workflows. Furthermore, the underlying end-to-end development processes are often inadequately documented and exhibit a positive publication bias, thereby limiting the opportunity to learn from prior efforts. Methods: This study employs a holistic, process-oriented approach to examining obstacles across the full development lifecycle of AI-based telemonitoring systems. Existing Cross Industry Standard Process for Data Mining (CRISP-DM) variants are synthesized into a structuring framework tailored to telemonitoring contexts and used to guide a qualitative case study of the KardioInterakt project, a German research initiative developing an AI-based telemonitoring system for HF management. Results: By systematically reconstructing decisions, constraints, and mitigation strategies and synthesizing them with prior work, we offer practice-oriented recommendations with potential transferability for the development of AI-based telemonitoring systems. These pertain to scoping and feasibility assessment, stakeholder involvement, data strategy, regulatory compliance, user-centered design, and transparent publication. Discussion: Our findings offer actionable guidance for the development of viable, trustworthy, robust, and regulatory-compliant AI-based telemonitoring solutions. The process-oriented recommendations address prevailing challenges and demonstrate how these can be managed across the development lifecycle, thereby promoting transparency and supporting successful integration into routine clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.